{"title_page": "Paul J. Tesar", "text_new": "{{COI|date=February 2020}}\n\n{{Infobox scientist\n| name = Paul J. Tesar\n| image = Paul Tesar, Crain's 40 under 40 (2019).jpg\n| image_size =\n| caption = \n| birth_date = <!-- {{Birth year and age|1981}} -->\n| birth_place = [[Cleveland, Ohio]], US\n| death_date =\n| death_place =\n| residence =\n| ethnicity =\n| fields = {{ubl|class=nowrap|[[Stem cell]] Biology|[[Developmental biology|Developmental Biology]]|[[Glia]]l Biology}}\n| workplaces = {{ubl|class=nowrap|[[Case Western Reserve University School of Medicine|Case Western Reserve School of Medicine]]|Convelo Therapeutics}}\n| alma_mater = {{ubl|class=nowrap|[[Case Western Reserve University]] (BS)|[[University of Oxford]] (DPhil)}}\n| doctoral_advisors = {{ubl|class=nowrap|[[Richard Gardner (embryologist)|Sir Richard Gardner]]|Ronald McKay}}\n| doctoral_students =\n| notable_students =\n| known_for = {{ubl|class=nowrap|Discovery of [[Epiblast-derived stem cell|epiblast stem cells]]..<ref>{{cite journal | vauthors = Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RD | display-authors = 6 | title = New cell lines from mouse epiblast share defining features with human embryonic stem cells | journal = Nature | volume = 448 | issue = 7150 | pages = 196\u20139 | date = July 2007 | pmid = 17597760 | doi = 10.1038/nature05972 | bibcode = 2007Natur.448..196T }}</ref>|[[remyelination|Myelin regeneration]]<ref>{{Cite journal|last=Najm|first=Fadi J.|last2=Madhavan|first2=Mayur|last3=Zaremba|first3=Anita|last4=Shick|first4=Elizabeth|last5=Karl|first5=Robert T.|last6=Factor|first6=Daniel C.|last7=Miller|first7=Tyler E.|last8=Nevin|first8=Zachary S.|last9=Kantor|first9=Christopher|last10=Sargent|first10=Alex|last11=Quick|first11=Kevin L.|date=June 2015|title=Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo|journal=Nature|volume=522|issue=7555|pages=216\u2013220|doi=10.1038/nature14335|pmid=25896324|pmc=4528969|issn=1476-4687}}</ref>}}\n| author_abbrev_bot =\n| author_abbrev_zoo =\n| influences =\n| influenced =\n| awards =\n| religion =\n| signature =\n| footnotes =\n}}\n\n'''Paul J. Tesar''' is an American [[Developmental biology|developmental biologist]] focused on [[regenerative medicine]]. Tesar is the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at Case Western Reserve University School of Medicine and co-founder of the biotechnology company Convelo Therapeutics.<ref name=\":3\">{{Cite web|url=https://www.businesswire.com/news/home/20180725005491/en/Convelo-Therapeutics-Develop-New-Regenerative-Medicines-Neurological|title=Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by Loss of Myelin|last=|first=|date=2018-07-25|website=www.businesswire.com|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Early life and education ==\nTesar was born in [[Cleveland]], Ohio.<ref name=\":9\">{{Cite news|url=https://newspapers.case.edu/cgi-bin/imageserver.pl?oid=OBS20040917-01&getpdf=true|title=The BriefCase|last=|first=|date=September 17, 2004|work=The Observer|access-date=|url-status=live}}</ref> He received his Bachelor of Science in Biology from Case Western Reserve University in 2003, graduating magna cum laude. He studied [[mesenchymal stem cell]] biology<ref name=\":7\">{{Cite web|url=https://thedaily.case.edu/school-of-medicine-faculty-member-receives-prestigious-award-for-stem-cell-research/|title=School of Medicine faculty member receives prestigious award for stem cell research|last=|first=|date=2015-02-05|website=The Daily|url-status=live|archive-url=|archive-date=|access-date=}}</ref> in the laboratories of Stephen Haynesworth and Arnold Caplan<ref name=\"Diekhoff Award\">{{cite web|url=https://thedaily.case.edu/coming-full-circle-paul-tesar-cwru-undergrad-mentee-receives-john-s-diekhoff-award-mentoring/|title=Coming full circle: Paul Tesar wins Diekhoff Award for Graduate Student Mentoring}}</ref> \n\nTesar received his [[Doctor of Philosophy|DPhil]] from the [[University of Oxford]] as a [[National Institutes of Health]] (NIH) Oxford-Cambridge Scholar in 2007.<ref>{{Cite web|url=https://biomedalliance.org/2018/08/07/tesar-03-continues-to-excel/|title=Tesar '03 Continues to Excel \u2013 International Biomedical Alliance|last=|first=|date=|website=|language=en-US|url-status=live|archive-url=|archive-date=|access-date=}}</ref>. He studied under Professor [[Richard Gardner (embryologist)|Sir Richard Gardner]] at the University of Oxford and Ron McKay at the [[National Institute of Neurological Disorders and Stroke]] at the NIH.<ref name=\":0\">{{Cite web|url=https://www.nature.com/articles/nj7556-381a|title=Turning point: Paul Tesar|last=|first=|date=|website=Nature|url-status=live|archive-url=|archive-date=|access-date=}}</ref> Tesar discovered a new type of pluripotent stem cell, epiblast stem cells as a graduate student.<ref name=\":0\" /> He was awarded both the [[Rosa Beddington]] Medal<ref name=\":5\">{{Cite web|url=http://bsdb.org/awards/the-beddington-medal/|title=The Beddington Medal|last=|first=|date=|website=BSDB - British Society for Developmental Biology|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and the [[Harold M. Weintraub]] Award<ref>{{Cite web|url=https://biomedalliance.org/project/paul-tesar/|title=Paul Tesar \u2013 International Biomedical Alliance|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> in 2008 for his graduate research.\n\n== Academic career ==\nIn 2010, Tesar joined the faculty at [[Case Western Reserve University School of Medicine]]<ref name=\":7\" /> as an Assistant Professor in the Department of Genetics and Genome Sciences.<ref name=\":0\" /> He became Associate Professor in 2014 and Professor in 2019.<ref name=\"Diekhoff Award\" /> Tesar holds the Dr. Donald and Ruth Weber Goodman Chair in Innovative Therapeutics.<ref name=\"Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics\">{{cite web|url=https://www.sciencedaily.com/releases/2018/10/181001130334.htm|title=Paul Tesar, PhD, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, more efficiently generates brain stem cells}}</ref>\n\nIn 2011, Tesar was named one of [[New York Stem Cell Foundation|The New York Stem Cell Foundation's]] Robertson Stem Cell Investigators<ref>{{Cite web|url=https://www.nature.com/naturecareers/events/event/11548|title={{!}} Nature Careers NYSCF - Robertson Investigators: Innovator Awards in Translational Stem Cell Research|last=|first=|date=|website=www.nature.com|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and was the recipient of the [[International Society for Stem Cell Research]] Outstanding Young Investigator Award in 2015.<ref>{{Cite web|url=https://www.isscr.org/professional-resources/news-publicationsss/isscr-news-articles/article-listing/2015/01/20/the-isscr-announces-2015-recipients-of-the-mcewen-award-for-innovation-the-isscr-bd-biosciences-outstanding-young-investigator-and-the-isscr-public-service-awards-20-january-2015|title=The ISSCR Announces 2015 Recipients of the McEwen Award for Innovation, the ISSCR-BD Biosciences Outstanding Young Investigator, and the ISSCR Public Service Awards, 20 January, 2015|last=|first=|date=|website=www.isscr.org|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Research ==\nTesar developed methods to generate and grow [[oligodendrocyte]]s and [[Oligodendrocyte progenitor cell|oligodendrocyte progenitors cells (OPCs)]] from [[pluripotent stem cells]] and skin cells<ref>{{Cite web|url=https://www.cbsnews.com/news/study-new-process-converts-skin-cells-into-brain-cells/|title=Study: New process converts skin cells into brain cells|last=|first=|date=|website=www.cbsnews.com|language=en-US|url-status=live|archive-url=|archive-date=|access-date=}}</ref><ref>{{Cite web|url=https://www.sciencedaily.com/releases/2013/04/130414193143.htm|title=Ordinary skin cells morphed into functional brain cells|last=|first=|date=|website=ScienceDaily|language=en|url-status=live|archive-url=|archive-date=|access-date=}}</ref>. He also made human brain [[Organoid|organoids]] containing human [[myelin]] called oligocortical spheroids.<ref name=\":6\">{{Cite journal|vauthors=Madhavan M, Nevin ZS, Shick HE, Garrison E, et al. |date=September 2018|title=Induction of myelinating oligodendrocytes in human cortical spheroids|journal=Nature Methods|volume=15|issue=9|pages=700\u201306|doi=10.1038/s41592-018-0081-4|pmid=30046099|pmc=6508550|issn=1548-7105}}</ref><ref>{{Cite web|url=https://www.sciencedaily.com/releases/2018/07/180726085756.htm|title=New method adds missing functionality to brain organoids: Protocol adds a new cell type enabling myelination in human 'mini-brains' for laboratory research|last=|first=|date=|website=ScienceDaily|language=en|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\nTesar identified drug that stimulate myelin regeneration and reverse paralysis in mice with [[multiple sclerosis]].<ref>{{Cite web|url=https://www.sciencedaily.com/releases/2015/04/150420111357.htm|title=Drugs stimulate body's own stem cells to replace the brain cells lost in multiple sclerosis|last=|first=|date=|website=ScienceDaily|url-status=live|archive-url=|archive-date=|access-date=}}</ref> These drugs inhibit enzymes in the [[cholesterol]] [[biosynthesis]] pathway to promote remyelination.<ref>{{Cite web|url=https://www.crainscleveland.com/article/20180725/news/169581/convelo-therapeutics-founded-discoveries-made-case-western-reserve|title=Convelo Therapeutics, founded on discoveries made at Case Western Reserve University School of Medicine, launches publicly|last=|first=|date=2018-07-25|website=Crain's Cleveland Business|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\nIn 2017 and 2018, Tesar generated OPCs and oligodendrocytes from patients with [[Pelizaeus\u2013Merzbacher disease]]<ref>{{Cite web|url=https://www.eurekalert.org/pub_releases/2017-03/cwru-sch033017.php|title=Stem cells help explain varied genetics behind rare neurologic disease|last=|first=|date=|website=EurekAlert!|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and defined the mechanism by which oligodendrocytes are lost.<ref>{{Cite web|url=https://www.sciencedaily.com/releases/2018/10/181001130334.htm|title=More efficiently generating brain stem cells: Technique improves understanding of myelin disease|last=|first=|date=|website=ScienceDaily|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\nTesar also identified [[CRISPR]] and [[antisense oligonucleotide]] therapeutics that restored myelination and function, and extended the lifespan of a mouse model of [[Pelizaeus\u2013Merzbacher disease|Pelizaeus-Merzbacher disease.]]<ref>{{Cite journal|last=Elitt|first=Matthew S.|last2=Barbar|first2=Lilianne|last3=Shick|first3=H. Elizabeth|last4=Powers|first4=Berit E.|last5=Maeno-Hikichi|first5=Yuka|last6=Madhavan|first6=Mayur|last7=Allan|first7=Kevin C.|last8=Nawash|first8=Baraa S.|last9=Nevin|first9=Zachary S.|last10=Olsen|first10=Hannah E.|last11=Hitomi|first11=Midori|date=2018-12-31|title=Therapeutic suppression of proteolipid protein rescues Pelizaeus-Merzbacher Disease in mice|url=https://www.biorxiv.org/content/10.1101/508192v1|journal=bioRxiv|pages=508192|doi=10.1101/508192}}</ref><ref>{{Cite web|url=https://www.drugtargetreview.com/news/35904/technique-brain-stem-cells/|title=New technique generates brain stem cells more efficiently|last=|first=|date=|website=Drug Target Review|language=en|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Convelo Therapeutics ==\nTesar and fellow Case Western professor Drew Adams co-founded Convelo Therapeutics, a biotechnology company that is focused on drug discovery and drug development for myelin disorders. The company was created in 2016 and publicly launched in 2018.<ref name=\"newswise spinout\">{{Cite press release |title=Case Western Reserve 'spinout' company, Convelo Therapeutics, partners with Genentech to develop medicines for neurological disorders |date=August 1, 2019 |url=https://www.newswise.com/articles/case-western-reserve-spinout-company-convelo-therapeutics-partners-with-genentech-to-develop-medicines-for-neurological-disorders |author=Case Western Reserve University |via=Newswise |url-status=live|author-link=Case Western Reserve University }}</ref> [[Derrick Rossi]] was appointed president and CEO. In 2019, Convelo announced a partnership with [[Genentech]], a member of the [[Roche Group]].<ref name=\"newswise spinout\" /><ref>{{Cite news|url=https://multiplesclerosisnewstoday.com/news-posts/2019/07/16/convelo-therapeutics-enters-into-collaboration-and-option-to-acquire-agreement-with-genentech-to-discover-novel-remyelinating-therapies/|title=Convelo, Genentech Join Forces to Develop MS Remyelination Therapies|last=Wexler | first=Marisa | date=2019-07-19|work=Multiple Sclerosis News Today|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Key publications ==\n* Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RD. [https://www.nature.com/articles/nature05972 New cell lines from mouse epiblast share defining features with human embryonic stem cells.] Nature. 2007\n* Najm FJ, Chenoweth JG, Anderson PD, Nadeau JH, Redline RW, McKay RD, Tesar PJ. [https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(11)00049-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS193459091100049X%3Fshowall%3Dtrue Isolation of epiblast stem cells from preimplantation mouse embryos]. Cell Stem Cell. 2011\n* Najm FJ, Zaremba A, Caprariello AV, Nayak S, Freundt EC, Scacheri PC, Miller RH, Tesar PJ. [https://www.nature.com/articles/nmeth.1712 Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells.] Nature Methods. 2011\n* Najm FJ, Lager AM, Zaremba A, Wyatt K, Caprariello AV, Factor DC, Karl RT, Maeda T, Miller RH, Tesar PJ. T[https://www.nature.com/articles/nbt.2561 ranscription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.] Nature Biotechnology. 2013\n* Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin \u00a0ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ. [https://www.nature.com/articles/nature14335 Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.] Nature. 2015\n* Madhavan M, Nevin ZS, Shick HE, Garrison E, Clarkson-Paredes C, Karl M, Clayton BLL, Factor DC, Allan KC, Barbar L, Jain T, Douvaras P, Fossati V, Miller RH, Tesar PJ. [https://www.nature.com/articles/s41592-018-0081-4 Induction of myelinating oligodendrocytes in human cortical spheroids.] Nature Methods. 2018\n* Hubler Z, Allimuthu D, Bederman I, Elitt MS, Madhavan M, Allan KC, Shick HE, Garrison E, T Karl M, Factor DC, Nevin ZS, Sax JL, Thompson MA, Fedorov Y, Jin J, Wilson WK, Giera M, Bracher F, Miller RH, Tesar PJ, Adams DJ. [https://www.nature.com/articles/s41586-018-0360-3 Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination.] Nature. 2018\n* Elitt MS, Barbar L,\u00a0 Shick HE,\u00a0 Powers BE, Maeno-Hikichi Y, Madhavan M,\u00a0 Allan KC,\u00a0 Nawash BS, Nevin ZS,\u00a0 Olsen HE, Hitomi M,\u00a0 LePage DF,\u00a0 Jiang W,\u00a0 Conlon RA, Rigo F,\u00a0 Tesar PJ. [https://www.biorxiv.org/content/10.1101/508192v1 Therapeutic suppression of proteolipid protein rescues Pelizaeus-Merzbacher Disease in mice.] bioRxiv 2018 \u00a0\n\n== Awards ==\n* The Beddington Medal from the [[British Society for Developmental Biology]] {{small|(2008)}}<ref name=\":5\" />\n* [[Harold M. Weintraub]] Award {{small|(2008)}}<ref>{{cite web|url=https://www.fredhutch.org/content/dam/www/research/divisions/basic-sciences/weintraub-award/WGSA_Archive.pdf| title=Harold M. Weintraub Awardees from 2001-2014}}</ref>\n* [[New York Stem Cell Foundation]] Robertson Investigator {{small|(2011)}}<ref name=\"Robertson Investigator\">{{cite web|url=https://nyscf.org/resources/nyscf-robertson-investigator-discovers-seeds-of-stem-cell-development/|title=NYSCF Robertson Investigator Paul Tesar}}</ref>\n* Outstanding Young Investigator Award, [[International Society for Stem Cell Research]] {{small|(2015)}}<ref name=\"ISCCR Young Investigator\">{{cite web|url=https://nyscf.org/resources/nyscf-robertson-investigator-wins-international-stem-cell-award/|title=NYSCF Investigator Paul Tesar Receives ISSCR Young Investigator Award}}</ref><ref name=\"ISCCR Young Investigator Announcement\">{{cite web|url=https://www.isscr.org/professional-resources/news-publicationsss/isscr-news-articles/article-listing/2015/01/20/the-isscr-announces-2015-recipients-of-the-mcewen-award-for-innovation-the-isscr-bd-biosciences-outstanding-young-investigator-and-the-isscr-public-service-awards-20-january-2015|title=Paul Tesar -ISSCR Young Investigator Award}}</ref>\n* Robertson Stem Cell Prize, [[New York Stem Cell Foundation]] {{small|(2017)}}<ref>{{cite web|url=https://nyscf.org/resources/paul-tesar-named-2017-nyscf-robertson-stem-cell-prize-recipient/|title= NYSCF Robertson Stem Cell Prize Awarded to Paul J. Tesar}}</ref>\n*40 Under 40, [[Crain's Cleveland Business]] {{small|(2019)}}<ref name=\":2\">{{Cite web|url=https://www.crainscleveland.com/awards/paul-tesar-forty-under-40-2019|title=Forty Under 40 - Paul Tesar|last=|first=|date=2019-11-15|website=Crain's Cleveland Business|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== References ==\n\n{{Reflist}}\n\n== External links ==\n* {{Official website|http://www.tesarlab.com|Tesar Lab website}}\n{{Authority control}}\n\n[[Category:American medical researchers]]\n[[Category:Stem cell researchers]]\n\n[[Category:Living people]]\n\n[[Category:Case Western Reserve University faculty]]\n[[Category:1981 births]]\n[[Category:Case Western Reserve University alumni]]\n", "text_old": "{{COI|date=February 2020}}\n\n{{Infobox scientist\n| name = Paul J. Tesar\n| image = Paul Tesar, Crain's 40 under 40 (2019).jpg\n| image_size =\n| caption = \n| birth_date = <!-- {{Birth year and age|1981}} -->\n| birth_place = [[Cleveland, Ohio]], US\n| death_date =\n| death_place =\n| residence =\n| ethnicity =\n| fields = {{ubl|class=nowrap|[[Stem cell]] Biology|[[Developmental biology|Developmental Biology]]|[[Glia]]l Biology}}\n| workplaces = {{ubl|class=nowrap|[[Case Western Reserve University School of Medicine|Case Western Reserve School of Medicine]]|Convelo Therapeutics}}\n| alma_mater = {{ubl|class=nowrap|[[Case Western Reserve University]] (BS)|[[University of Oxford]] (DPhil)}}\n| doctoral_advisors = {{ubl|class=nowrap|[[Richard Gardner (embryologist)|Sir Richard Gardner]]|Ronald McKay}}\n| doctoral_students =\n| notable_students =\n| known_for = {{ubl|class=nowrap|Discovery of [[Epiblast-derived stem cell|epiblast stem cells]]..<ref>{{cite journal | vauthors = Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RD | display-authors = 6 | title = New cell lines from mouse epiblast share defining features with human embryonic stem cells | journal = Nature | volume = 448 | issue = 7150 | pages = 196\u20139 | date = July 2007 | pmid = 17597760 | doi = 10.1038/nature05972 | bibcode = 2007Natur.448..196T }}</ref>|[[remyelination|Myelin regeneration]]<ref>{{Cite journal|last=Najm|first=Fadi J.|last2=Madhavan|first2=Mayur|last3=Zaremba|first3=Anita|last4=Shick|first4=Elizabeth|last5=Karl|first5=Robert T.|last6=Factor|first6=Daniel C.|last7=Miller|first7=Tyler E.|last8=Nevin|first8=Zachary S.|last9=Kantor|first9=Christopher|last10=Sargent|first10=Alex|last11=Quick|first11=Kevin L.|date=June 2015|title=Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo|journal=Nature|volume=522|issue=7555|pages=216\u2013220|doi=10.1038/nature14335|pmid=25896324|pmc=4528969|issn=1476-4687}}</ref>}}\n| author_abbrev_bot =\n| author_abbrev_zoo =\n| influences =\n| influenced =\n| awards =\n| religion =\n| signature =\n| footnotes =\n}}\n\n'''Paul J. Tesar''' is an American [[Developmental biology|developmental biologist]] focused on [[regenerative medicine]]. Tesar is the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics at Case Western Reserve University School of Medicine and co-founder of the biotechnology company Convelo Therapeutics.<ref name=\":3\">{{Cite web|url=https://www.businesswire.com/news/home/20180725005491/en/Convelo-Therapeutics-Develop-New-Regenerative-Medicines-Neurological|title=Convelo Therapeutics to Develop New Regenerative Medicines for Neurological Disease Characterized by Loss of Myelin|last=|first=|date=2018-07-25|website=www.businesswire.com|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Early life and education ==\nTesar was born in [[Cleveland]], Ohio.<ref name=\":9\">{{Cite news|url=https://newspapers.case.edu/cgi-bin/imageserver.pl?oid=OBS20040917-01&getpdf=true|title=The BriefCase|last=|first=|date=September 17, 2004|work=The Observer|access-date=|url-status=live}}</ref> He received his Bachelor of Science in Biology from Case Western Reserve University in 2003, graduating magna cum laude. He studied [[mesenchymal stem cell]] biology<ref name=\":7\">{{Cite web|url=https://thedaily.case.edu/school-of-medicine-faculty-member-receives-prestigious-award-for-stem-cell-research/|title=School of Medicine faculty member receives prestigious award for stem cell research|last=|first=|date=2015-02-05|website=The Daily|url-status=live|archive-url=|archive-date=|access-date=}}</ref> in the laboratories of Stephen Haynesworth and Arnold Caplan<ref name=\"Diekhoff Award\">{{cite web|url=https://thedaily.case.edu/coming-full-circle-paul-tesar-cwru-undergrad-mentee-receives-john-s-diekhoff-award-mentoring/|title=Coming full circle: Paul Tesar wins Diekhoff Award for Graduate Student Mentoring}}</ref> \n\nTesar received his [[Doctor of Philosophy|DPhil]] from the [[University of Oxford]] as a [[National Institutes of Health]] (NIH) Oxford-Cambridge Scholar in 2007.<ref>{{Cite web|url=https://biomedalliance.org/2018/08/07/tesar-03-continues-to-excel/|title=Tesar '03 Continues to Excel \u2013 International Biomedical Alliance|last=|first=|date=|website=|language=en-US|url-status=live|archive-url=|archive-date=|access-date=}}</ref>. He studied under Professor [[Richard Gardner (embryologist)|Sir Richard Gardner]] at the University of Oxford and Ron McKay at the [[National Institute of Neurological Disorders and Stroke]] at the NIH.<ref name=\":0\">{{Cite web|url=https://www.nature.com/articles/nj7556-381a|title=Turning point: Paul Tesar|last=|first=|date=|website=Nature|url-status=live|archive-url=|archive-date=|access-date=}}</ref> Tesar discovered a new type of pluripotent stem cell, epiblast stem cells as a graduate student.<ref name=\":0\" /> He was awarded both the [[Rosa Beddington]] Medal<ref name=\":5\">{{Cite web|url=http://bsdb.org/awards/the-beddington-medal/|title=The Beddington Medal|last=|first=|date=|website=BSDB - British Society for Developmental Biology|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and the [[Harold M. Weintraub]] Award<ref>{{Cite web|url=https://biomedalliance.org/project/paul-tesar/|title=Paul Tesar \u2013 International Biomedical Alliance|last=|first=|date=|website=|url-status=live|archive-url=|archive-date=|access-date=}}</ref> in 2008 for his graduate research.\n\n== Academic career ==\nIn 2010, Tesar joined the faculty at [[Case Western Reserve University School of Medicine]]<ref name=\":7\" /> as an Assistant Professor in the Department of Genetics and Genome Sciences.<ref name=\":0\" /> He became Associate Professor in 2014 and Professor in 2019.<ref name=\"Diekhoff Award\" /> Tesar holds the Dr. Donald and Ruth Weber Goodman Chair in Innovative Therapeutics.<ref name=\"Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics\">{{cite web|url=https://www.sciencedaily.com/releases/2018/10/181001130334.htm|title=Paul Tesar, PhD, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics, more efficiently generates brain stem cells}}</ref>\n\nIn 2011, Tesar was named one of [[New York Stem Cell Foundation|The New York Stem Cell Foundation's]] Robertson Stem Cell Investigators<ref>{{Cite web|url=https://www.nature.com/naturecareers/events/event/11548|title={{!}} Nature Careers NYSCF - Robertson Investigators: Innovator Awards in Translational Stem Cell Research|last=|first=|date=|website=www.nature.com|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and was the recipient of the [[International Society for Stem Cell Research]] Outstanding Young Investigator Award in 2015.<ref>{{Cite web|url=https://www.isscr.org/professional-resources/news-publicationsss/isscr-news-articles/article-listing/2015/01/20/the-isscr-announces-2015-recipients-of-the-mcewen-award-for-innovation-the-isscr-bd-biosciences-outstanding-young-investigator-and-the-isscr-public-service-awards-20-january-2015|title=The ISSCR Announces 2015 Recipients of the McEwen Award for Innovation, the ISSCR-BD Biosciences Outstanding Young Investigator, and the ISSCR Public Service Awards, 20 January, 2015|last=|first=|date=|website=www.isscr.org|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Research ==\nTesar developed methods to generate and grow [[oligodendrocyte]]s and [[Oligodendrocyte progenitor cell|oligodendrocyte progenitors cells (OPCs)]] from [[pluripotent stem cells]] and skin cells<ref>{{Cite web|url=https://www.cbsnews.com/news/study-new-process-converts-skin-cells-into-brain-cells/|title=Study: New process converts skin cells into brain cells|website=www.cbsnews.com|language=en-US|access-date=2020-04-01}}</ref><ref>{{Cite web|url=https://www.sciencedaily.com/releases/2013/04/130414193143.htm|title=Ordinary skin cells morphed into functional brain cells|website=ScienceDaily|language=en|access-date=2020-04-01}}</ref>. He also made human brain [[Organoid|organoids]] containing human [[myelin]] called oligocortical spheroids.<ref name=\":6\">{{Cite journal|vauthors=Madhavan M, Nevin ZS, Shick HE, Garrison E, et al. |date=September 2018|title=Induction of myelinating oligodendrocytes in human cortical spheroids|journal=Nature Methods|volume=15|issue=9|pages=700\u201306|doi=10.1038/s41592-018-0081-4|pmid=30046099|pmc=6508550|issn=1548-7105}}</ref><ref>{{Cite web|url=https://www.sciencedaily.com/releases/2018/07/180726085756.htm|title=New method adds missing functionality to brain organoids: Protocol adds a new cell type enabling myelination in human 'mini-brains' for laboratory research|last=|first=|date=|website=ScienceDaily|language=en|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\nTesar identified drug that stimulate myelin regeneration and reverse paralysis in mice with [[multiple sclerosis]].<ref>{{Cite web|url=https://www.sciencedaily.com/releases/2015/04/150420111357.htm|title=Drugs stimulate body's own stem cells to replace the brain cells lost in multiple sclerosis|last=|first=|date=|website=ScienceDaily|url-status=live|archive-url=|archive-date=|access-date=}}</ref> These drugs inhibit enzymes in the [[cholesterol]] [[biosynthesis]] pathway to promote remyelination.<ref>{{Cite web|url=https://www.crainscleveland.com/article/20180725/news/169581/convelo-therapeutics-founded-discoveries-made-case-western-reserve|title=Convelo Therapeutics, founded on discoveries made at Case Western Reserve University School of Medicine, launches publicly|last=|first=|date=2018-07-25|website=Crain's Cleveland Business|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\nIn 2017 and 2018, Tesar generated OPCs and oligodendrocytes from patients with [[Pelizaeus\u2013Merzbacher disease]]<ref>{{Cite web|url=https://www.eurekalert.org/pub_releases/2017-03/cwru-sch033017.php|title=Stem cells help explain varied genetics behind rare neurologic disease|last=|first=|date=|website=EurekAlert!|url-status=live|archive-url=|archive-date=|access-date=}}</ref> and defined the mechanism by which oligodendrocytes are lost.<ref>{{Cite web|url=https://www.sciencedaily.com/releases/2018/10/181001130334.htm|title=More efficiently generating brain stem cells: Technique improves understanding of myelin disease|last=|first=|date=|website=ScienceDaily|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\nTesar also identified [[CRISPR]] and [[antisense oligonucleotide]] therapeutics that restored myelination and function, and extended the lifespan of a mouse model of [[Pelizaeus\u2013Merzbacher disease|Pelizaeus-Merzbacher disease.]]<ref>{{Cite journal|last=Elitt|first=Matthew S.|last2=Barbar|first2=Lilianne|last3=Shick|first3=H. Elizabeth|last4=Powers|first4=Berit E.|last5=Maeno-Hikichi|first5=Yuka|last6=Madhavan|first6=Mayur|last7=Allan|first7=Kevin C.|last8=Nawash|first8=Baraa S.|last9=Nevin|first9=Zachary S.|last10=Olsen|first10=Hannah E.|last11=Hitomi|first11=Midori|date=2018-12-31|title=Therapeutic suppression of proteolipid protein rescues Pelizaeus-Merzbacher Disease in mice|url=https://www.biorxiv.org/content/10.1101/508192v1|journal=bioRxiv|pages=508192|doi=10.1101/508192}}</ref><ref>{{Cite web|url=https://www.drugtargetreview.com/news/35904/technique-brain-stem-cells/|title=New technique generates brain stem cells more efficiently|last=|first=|date=|website=Drug Target Review|language=en|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Convelo Therapeutics ==\nTesar and fellow Case Western professor Drew Adams co-founded Convelo Therapeutics, a biotechnology company that is focused on drug discovery and drug development for myelin disorders. The company was created in 2016 and publicly launched in 2018.<ref name=\"newswise spinout\">{{Cite press release |title=Case Western Reserve 'spinout' company, Convelo Therapeutics, partners with Genentech to develop medicines for neurological disorders |date=August 1, 2019 |url=https://www.newswise.com/articles/case-western-reserve-spinout-company-convelo-therapeutics-partners-with-genentech-to-develop-medicines-for-neurological-disorders |author=Case Western Reserve University |via=Newswise |url-status=live|author-link=Case Western Reserve University }}</ref> [[Derrick Rossi]] was appointed president and CEO. In 2019, Convelo announced a partnership with [[Genentech]], a member of the [[Roche Group]].<ref name=\"newswise spinout\" /><ref>{{Cite news|url=https://multiplesclerosisnewstoday.com/news-posts/2019/07/16/convelo-therapeutics-enters-into-collaboration-and-option-to-acquire-agreement-with-genentech-to-discover-novel-remyelinating-therapies/|title=Convelo, Genentech Join Forces to Develop MS Remyelination Therapies|last=Wexler | first=Marisa | date=2019-07-19|work=Multiple Sclerosis News Today|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== Key publications ==\n* Tesar PJ, Chenoweth JG, Brook FA, Davies TJ, Evans EP, Mack DL, Gardner RL, McKay RD. [https://www.nature.com/articles/nature05972 New cell lines from mouse epiblast share defining features with human embryonic stem cells.] Nature. 2007\n* Najm FJ, Chenoweth JG, Anderson PD, Nadeau JH, Redline RW, McKay RD, Tesar PJ. [https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(11)00049-X?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS193459091100049X%3Fshowall%3Dtrue Isolation of epiblast stem cells from preimplantation mouse embryos]. Cell Stem Cell. 2011\n* Najm FJ, Zaremba A, Caprariello AV, Nayak S, Freundt EC, Scacheri PC, Miller RH, Tesar PJ. [https://www.nature.com/articles/nmeth.1712 Rapid and robust generation of functional oligodendrocyte progenitor cells from epiblast stem cells.] Nature Methods. 2011\n* Najm FJ, Lager AM, Zaremba A, Wyatt K, Caprariello AV, Factor DC, Karl RT, Maeda T, Miller RH, Tesar PJ. T[https://www.nature.com/articles/nbt.2561 ranscription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.] Nature Biotechnology. 2013\n* Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, Miller TE, Nevin \u00a0ZS, Kantor C, Sargent A, Quick KL, Schlatzer DM, Tang H, Papoian R, Brimacombe KR, Shen M, Boxer MB, Jadhav A, Robinson AP, Podojil JR, Miller SD, Miller RH, Tesar PJ. [https://www.nature.com/articles/nature14335 Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo.] Nature. 2015\n* Madhavan M, Nevin ZS, Shick HE, Garrison E, Clarkson-Paredes C, Karl M, Clayton BLL, Factor DC, Allan KC, Barbar L, Jain T, Douvaras P, Fossati V, Miller RH, Tesar PJ. [https://www.nature.com/articles/s41592-018-0081-4 Induction of myelinating oligodendrocytes in human cortical spheroids.] Nature Methods. 2018\n* Hubler Z, Allimuthu D, Bederman I, Elitt MS, Madhavan M, Allan KC, Shick HE, Garrison E, T Karl M, Factor DC, Nevin ZS, Sax JL, Thompson MA, Fedorov Y, Jin J, Wilson WK, Giera M, Bracher F, Miller RH, Tesar PJ, Adams DJ. [https://www.nature.com/articles/s41586-018-0360-3 Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination.] Nature. 2018\n* Elitt MS, Barbar L,\u00a0 Shick HE,\u00a0 Powers BE, Maeno-Hikichi Y, Madhavan M,\u00a0 Allan KC,\u00a0 Nawash BS, Nevin ZS,\u00a0 Olsen HE, Hitomi M,\u00a0 LePage DF,\u00a0 Jiang W,\u00a0 Conlon RA, Rigo F,\u00a0 Tesar PJ. [https://www.biorxiv.org/content/10.1101/508192v1 Therapeutic suppression of proteolipid protein rescues Pelizaeus-Merzbacher Disease in mice.] bioRxiv 2018 \u00a0\n\n== Awards ==\n* The Beddington Medal from the [[British Society for Developmental Biology]] {{small|(2008)}}<ref name=\":5\" />\n* [[Harold M. Weintraub]] Award {{small|(2008)}}<ref>{{cite web|url=https://www.fredhutch.org/content/dam/www/research/divisions/basic-sciences/weintraub-award/WGSA_Archive.pdf| title=Harold M. Weintraub Awardees from 2001-2014}}</ref>\n* [[New York Stem Cell Foundation]] Robertson Investigator {{small|(2011)}}<ref name=\"Robertson Investigator\">{{cite web|url=https://nyscf.org/resources/nyscf-robertson-investigator-discovers-seeds-of-stem-cell-development/|title=NYSCF Robertson Investigator Paul Tesar}}</ref>\n* Outstanding Young Investigator Award, [[International Society for Stem Cell Research]] {{small|(2015)}}<ref name=\"ISCCR Young Investigator\">{{cite web|url=https://nyscf.org/resources/nyscf-robertson-investigator-wins-international-stem-cell-award/|title=NYSCF Investigator Paul Tesar Receives ISSCR Young Investigator Award}}</ref><ref name=\"ISCCR Young Investigator Announcement\">{{cite web|url=https://www.isscr.org/professional-resources/news-publicationsss/isscr-news-articles/article-listing/2015/01/20/the-isscr-announces-2015-recipients-of-the-mcewen-award-for-innovation-the-isscr-bd-biosciences-outstanding-young-investigator-and-the-isscr-public-service-awards-20-january-2015|title=Paul Tesar -ISSCR Young Investigator Award}}</ref>\n* Robertson Stem Cell Prize, [[New York Stem Cell Foundation]] {{small|(2017)}}<ref>{{cite web|url=https://nyscf.org/resources/paul-tesar-named-2017-nyscf-robertson-stem-cell-prize-recipient/|title= NYSCF Robertson Stem Cell Prize Awarded to Paul J. Tesar}}</ref>\n*40 Under 40, [[Crain's Cleveland Business]] {{small|(2019)}}<ref name=\":2\">{{Cite web|url=https://www.crainscleveland.com/awards/paul-tesar-forty-under-40-2019|title=Forty Under 40 - Paul Tesar|last=|first=|date=2019-11-15|website=Crain's Cleveland Business|url-status=live|archive-url=|archive-date=|access-date=}}</ref>\n\n== References ==\n\n{{Reflist}}\n\n== External links ==\n* {{Official website|http://www.tesarlab.com|Tesar Lab website}}\n{{Authority control}}\n\n[[Category:American medical researchers]]\n[[Category:Stem cell researchers]]\n\n[[Category:Living people]]\n\n[[Category:Case Western Reserve University faculty]]\n[[Category:1981 births]]\n[[Category:Case Western Reserve University alumni]]\n", "name_user": "Marissascavuzzo", "label": "safe", "comment": "", "url_page": "//en.wikipedia.org/wiki/Paul_J._Tesar"}
